Searle & Co. Aytu Biopharma, Inc Transaction History

Searle & Co.

  • $396 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$6.23 - $9.88 $87,220 - $138,320
-14,000 Closed
0 $0
Q4 2020

Feb 04, 2021
BUY
$5.98 - $13.5 $83,720 - $189,000
14,000 New
14,000 $84,000

Others Institutions Holding AYTU

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AYTU BIOPHARMA, INC

AYTU Quotes by TradingView
  • Ticker AYTU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 62,432,700
  • Market Cap $122M
  • Description
  • Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...
More about AYTU
Track This Portfolio

Track Searle & Co. Portfolio

Follow Searle & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email